Will a clinical study really boost the value of your nutraceutical?
Matevž Ambrožič
Advertisement
Matevž Ambrožič is marketing and PR director at PharmaLinea Ltd. (Ljubljana, Slovenia). He has an academic background in biochemistry with a specialty in protein biochemistry. Following his research position at Stockholm University and development position at Novartis, Ambrožič applied his knowledge in the food supplement industry, leading marketing at PharmaLinea.
Articles by Matevž Ambrožič
Five key strategies for immune health brands, from private-label food supplements manufacturer PharmaLinea.
Four strategies to deal with inflation in 2023, from private-label food supplements manufacturer PharmaLinea.
Advertisement
Latest Updated Articles
How can brands address inflation in 2023?January 4th 2023
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
A New Frontier in Eye Health: Digital Wellness, Bioavailability, and the Eye-Brain Connection
2
Finished Product Clinical Validation Emerges as a Competitive Differentiator in the Supplement Industry
3
Lion’s Mane Ingredient Targets Standardized Erinacine A
4
Clasado Biosciences Partners with Prokopton SAS to Expand Bimuno GOS Distribution in France
5